WJPR Citation New

  All Since 2020
 Citation  8502  4519
 h-index  30  23
 i10-index  227  96

Login

Best Article Awards

World Journal of Pharmaceutical Research (WJPR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.
Best Paper Award :
Dr. Dhrubo Jyoti Sen
Download Article: Click Here

Search

Track Your Article

Abstract

A CRITICAL REVIEW ON THE BENEFITS OF SHIVA GUTIKA RASAYANA

Dr. Deepa*, Dr. Surekha Pai and Dr. K. Kiran

.

Abstract

Rasayana belongs to the sub-category of Swasthasyorjaskara under the division of Bheshaja (Medicine). Primarily the Rasayana are utilised to promote the health because of its rejuvenation action. It acts on multisystems of the body, helps to prevent as well as to cure from the disease; one such example is Shiva Gutika, it is said to be propounded by Lord Shiva as per the literatures of Ayurveda. This paper enlightens the concept of Rasayana and its importance by analysing its health benefits in human life along with an example of Shiva Gutika. Shiva Gutika is said to be a Sarvaaamaya Nashaka, this indicates a therapeutic effect on the disorders of both Shareera and Manas by acting on all 14 Srotas i.e. from Rasa vaha to Shukra vaha including Manovaha srotas. Hereby making an attempt to analyse its Rasayana effect on healthy as well as various diseased conditions with respect to the references found in Ayurvedic literature and also by quoting few of the examples of previously conducted research studies on Shiva Gutika for evaluating its efficacy in certain disorders.

Keywords: Rasayana, Rejuvenation, Shiva Gutika, Sarvaamaya Nashaka.


[Full Text Article]  [Download Certificate]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More